With long COVID health risks, Chicago organizations create safe spaces, events for vulnerable communities
Five years since COVID-19 was declared a pandemic by the World Health Organization, people who are still vulnerable to the ...
Volition Introduces Nu.Q® Cancer Blood Test in New Industry Primer for Lung Cancer
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the release of Volition's new lung cancer primer, "Lung Cancer: Hope of a Brighter Tomorrow ...